Oracle
ORCL
NVIDIA
NVDA
Microsoft
MSFT
D.R. Horton
DHI
Lennar Corp
LEN
US Stock MarketDetailed Quotes
PHIO Phio Pharmaceuticals
- 2.2900
- -0.1900-7.66%
Close Jan 22 16:00 ET
- 2.2500
- -0.0400-1.75%
Post 20:01 ET
10.94MMarket Cap-0.23P/E (TTM)
2.4900High2.2005Low1.02MVolume2.3500Open2.4800Pre Close2.35MTurnover22.39%Turnover RatioLossP/E (Static)4.78MShares10.350052wk High2.21P/B10.40MFloat Cap1.530052wk Low--Dividend TTM4.54MShs Float3118.4994Historical High--Div YieldTTM11.67%Amplitude1.5300Historical Low2.3110Avg Price1Lot Size
Phio Pharmaceuticals News
Phio Pharmaceuticals | D: Filing D
Phio Pharmaceuticals | D: Filing D
Phio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Infarinato Robert M.
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Freeman Jonathan E
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bitterman Robert J
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BRADFORD PATRICIA A
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ferrara Robert L
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lockshin Curtis
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Infarinato Robert M.
Phio Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Infarinato Robert M.
Phio Pharmaceuticals | D: Filing D
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bitterman Robert J
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bitterman Robert J
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kontulis Caitlin
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bitterman Robert J
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bitterman Robert J
Phio Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kontulis Caitlin
Phio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%), etc.
Phio Pharmaceuticals | D: Filing D
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.